Plus Library

Displaying 2,476 - 2,500 of 2,875

Attracting, Recruiting and Retaining the Oncology Pharmacy Talent
Attracting, Recruiting and Retaining the Oncology Pharmacy Talent
Dina Dumercy McHenry, PharmD, MBA, BCPS, BCOP & Glenn Fonte, PharmD & Kenneth Komorny, PharmD, BCPS & Scott Freeswick, PharmD, MS & Khang Pham, PharmD, BCSCP
Attracting, Recruiting and Retaining the Oncology Pharmacy Talent
Attracting, Recruiting and Retaining the Oncology Pharmacy Talent
Dina Dumercy McHenry, PharmD, MBA, BCPS, BCOP & Glenn Fonte, PharmD & Kenneth Komorny, PharmD, BCPS & Scott Freeswick, PharmD, MS & Khang Pham, PharmD, BCSCP
Post Graduate Year II Oncology Residency Training; the South Florida Before, After, and Future Journey
Post Graduate Year II Oncology Residency Training; the South Florida Before, After, and Future Journey
Frank Gentile, PharmD, BCOP & Shreya Shah, PharmD, BCOP, & Jessica Unzaga, PharmD, BCOP
Oncology Pharmacy Strategy Informed by Pharmacy Business Affairs Analytics
Oncology Pharmacy Strategy Informed by Pharmacy Business Affairs Analytics
Halena Leah Marcelin, PharmD, MS & Courtney Zephir, MBA
Oncology Pharmacy Strategy Informed by Pharmacy Business Affairs Analytics
Oncology Pharmacy Strategy Informed by Pharmacy Business Affairs Analytics
Halena Leah Marcelin, PharmD, MS & Courtney Zephir, MBA
Oncology Pharmacy Operations Efficiency Journey
Oncology Pharmacy Operations Efficiency Journey
Jessica Lemoine, PharmD, MS & Ernesto Perez, PharmD
Oncology Pharmacy Operations Efficiency Journey
Oncology Pharmacy Operations Efficiency Journey
Jessica Lemoine, PharmD, MS & Ernesto Perez, PharmD
Access to Biosimilars and New Indications
Access to Biosimilars and New Indications
Jorge Garcia, PharmD, MS, MHA, MBA, FACHE
Biosimilars as Front-Line Options for Cancer Care
Biosimilars as Front-Line Options for Cancer Care
Jorge Garcia, PharmD, MS, MHA, MBA, FACHE
Will Biosimilars Reduce Financial Toxicity of Cancer Therapy
Will Biosimilars Reduce Financial Toxicity of Cancer Therapy
Jorge J. Garcia, PharmD, MS, MHA, MBA, FACCC, FACHE
Integration of Biosimilars in Oncology Care
Integration of Biosimilars in Oncology Care
Jorge J. Garcia, PharmD, MS, MHA, MBA, FACHE
Biosimilars as Front Line Options for Cancer Care
Biosimilars as Front Line Options for Cancer Care
Jorge J. García, PharmD, MS, MHA, MBA, FACHE
Biosimilars, Beyond the Scientific Review
Biosimilars, Beyond the Scientific Review
Jorge J. Garcia, PharmD, MS, MHA, MBA, FACHE
Biosimilars as Front-Line Options for Cancer Care
Biosimilars as Front-Line Options for Cancer Care
Jorge J. García, PharmD, MS, MHA, MBA, FACHE
Drug Brown and White Bagging: What is It and Where Does it Lead Us?
Drug Brown and White Bagging: What is It and Where Does it Lead Us?
Jorge J. García, PharmD, MS, MHA, MBA, FACHE
Integration of Biosimilars in Oncology Care
Integration of Biosimilars in Oncology Care
Jorge J. Garcia, PharmD, MS, MHA, MBA, FACHE